Market revenue in 2023 | USD 1,085.6 million |
Market revenue in 2030 | USD 1,924.5 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Nylon |
Fastest growing segment | Polyurethane |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nylon, Polyurethane, Other Material Type |
Key market players worldwide | Medtronic PLC, Terumo Corp, Cardinal Health Inc, Boston Scientific Corp, Traeger Inc, BIOTRONIK, Surmodics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pta balloon catheter market will help companies and investors design strategic landscapes.
Nylon was the largest segment with a revenue share of 49.38% in 2023. Horizon Databook has segmented the U.S. pta balloon catheter market based on nylon, polyurethane, other material type covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the largest share of the North America PTA balloon catheters market. Some factors responsible for its dominance are an increase in the incidence of cardiovascular diseases, introduction of technologically advanced products, and presence of several key players in the market. Prevalence of Peripheral Arterial Disease (PAD) in the U.S. is on the rise, according to CDC, around 6.5 million people in the age group of 40 years and above are suffering from PAD.
Such an increase in the prevalence of PAD indicates rise in number of percutaneous coronary intervention (PCI) which is expected to boost market growth. Introduction of technologically advanced products in the market is anticipated to propel market growth.
For instance, a recent innovation that could provide a paradigm shift in the treatment of calcified vessels is the Shockwave endovascular lithotripsy system, which was approved by the FDA in February 2021 for use in coronary arteries. It combines a low-pressure balloon attached to a catheter to deliver bursts of sonic energy to break down calcium.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pta balloon catheter market , including forecasts for subscribers. This country databook contains high-level insights into U.S. pta balloon catheter market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account